Safety and Efficacy of Camrelizumab for High-risk NMIBC Failing BCG Treatment

Name: Safety and Efficacy of Camrelizumab for High-risk NMIBC Failing BCG Treatment
License: Public Domain

Fudan University

ClinicalTrials.gov · Datasets · License: Public Domain

urinary bladder neoplasms, immunotherapy

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 253011
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.